References
- Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., >Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., and Nagy A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435–439.
- Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O’Shea K. S., PowellBraxton L., Hillan K. J. and Moore M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439–442.
- Miquerol L., Langille B.L., and Nagy A. (2000) Embryonic development is disrupted by modest increase in vascular endothelial growth factor gene expression. Development, 127, 3941–3946.
- Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., Betsholtz C., and Shima. D.T. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes & Development, 16, 2684–2698.